For: | Chillarón JJ, Roux JAFL, Benaiges D, Pedro-Botet J. Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen. World J Clin Cases 2014; 2(9): 415-421 [PMID: 25232543 DOI: 10.12998/wjcc.v2.i9.415] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v2/i9/415.htm |
Number | Citing Articles |
1 |
M. Tajabadi-Ebrahimi, N. Sharifi, A. Farrokhian, F. Raygan, F. Karamali, R. Razzaghi, S. Taheri, Z. Asemi. A Randomized Controlled Clinical Trial Investigating the Effect of
Synbiotic Administration on Markers of Insulin Metabolism and Lipid Profiles in
Overweight Type 2 Diabetic Patients with Coronary Heart Disease. Experimental and Clinical Endocrinology & Diabetes 2017; 125(01): 21 doi: 10.1055/s-0042-105441
|
2 |
Eiichiro Kanda, Atsushi Suzuki, Masaki Makino, Hiroo Tsubota, Satomi Kanemata, Koichi Shirakawa, Toshitaka Yajima. Machine learning models for prediction of HF and CKD development in early-stage type 2 diabetes patients. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-24562-2
|
3 |
Beauty Akter, Mohd Salleh Rabeta, Mohamad Hafizi Abu Bakar. Synbiotic Efficacy as Therapeutic Approach in Human Disease: A Review. Pertanika Journal of Tropical Agricultural Science 2021; 44(1) doi: 10.47836/pjtas.44.1.04
|
4 |
Cui Lianqun. Clinical Significance of Arterial Stiffness and Thickness Biomarkers in Type 2 Diabetes Mellitus: An Up-To-Date Meta-Analysis. Medical Science Monitor 2015; 21: 2467 doi: 10.12659/MSM.894693
|